Skip to content
healthcare.dev

TADALAFIL

NDC 13668-565, TADALAFIL, tablet, from Torrent Pharmaceuticals Limited.

Product NDC
13668-565
Status
Listed
Labeler
Torrent Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211839
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13668-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TADALAFIL2.5 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
13668-565-0513668056505500 TABLET in 1 BOTTLE (13668-565-05)
13668-565-301366805653030 TABLET in 1 BOTTLE (13668-565-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3ea7612b-b004-43ef-accc-34c8ec5146b8
  • NADAC price for package 13668056530

    GET /v1/drugs/nadac/13668056530

Use it

Look up 13668-565 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13668-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13668-565. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.